Test Overview
Clinical Utility
Monitoring the Flecainide concentration is used to assure compliance and avoid toxicity of this cardiac drug used to treat ventricular tachycardia and premature contractions.
Method
Chromatography/Mass Spectrometry
Result Included
Flecainide
Aliases/Synonyms
Tambocor®
Specimen
Specimen Type
Avoid gel separator tubesSerum
Plasma (EDTA)
Volume
Sample Volume
2.0 mL
Minimum Volume
0.5 mL
Specimen Comment
Avoid gel separator tubes.
Collection & Handling
Collection Instructions
Collect trough specimen within 1 hour prior to next dose.
Handling Information
Store and send frozen.
Stability
| Ambient | Refrigerated | Frozen |
|---|---|---|
| 5 days | 7 days | 30 days |
Rejection Criteria
| Criteria | Specification |
|---|---|
| Specimen | Gel-separator tube |
| Hemolysis | Gross |
| Lipemia | Present |
Performance & Interpretation
Turnaround Time
11 days
Results
Name
Units
Reference Range
Conversion
-
Flecainidemcg/mL0.20 - 0.99
Referral Location
Out-of-Country
Interface & Setup
HL7 Interface Codes
| Order Code | Result Name | Result Codes | Units |
|---|---|---|---|
| FLECA S | FLECAINIDE | 63100 | mcg/mL |
Test Version
Last Updated
2023-09-08